These companies are benefiting from a tidal wave of demand for new weight-loss drugs.

Hims & Hers Health, Inc. HIMS trended on Wednesday after the company outlined an expanded weight-management push tied to ...

Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would ...

The crucial question is whether the terms of the partnership allow for profitable expansion or merely position HIMS as a ...

The drama and uncertainty around Novo Nordisk and Hims & Hers Health might finally be ending.

Hims & Hers stock traded more than 40% higher after the deal was announced.

Novo Nordisk A/S plans to sell its weight-loss drugs on Hims & Hers Health Inc.’s platform, according to a person familiar with the matter, ending a highly public feud between the two companies that ...

March 9 (Reuters) - Hims & Hers' shares were up over 40% on Monday, after Novo Nordisk agreed to sell its blockbuster Wegovy ...

HIMS stock soars on a settlement and partnership with Novo Nordisk. But Hims & Hers shares are unlikely to sustain these ...

Hims & Hers Health Inc. surged after Novo Nordisk A/S was said to have ended its public feud with the company with an agreement to sell its weight-loss drugs on the Hims platform.

Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have ...

March 6 (Reuters) - Wegovy maker Novo Nordisk plans to sell its weight-loss drugs on Hims & Hers Health platform, bringing an end to a dispute between the two companies that escalated into a legal ...